BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3326814)

  • 1. S-100 protein: a prognostic indicator in cutaneous malignant melanoma?
    Kernohan NM; Rankin R
    Histopathology; 1987 Dec; 11(12):1285-93. PubMed ID: 3326814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application.
    Nakajima T; Watanabe S; Sato Y; Kameya T; Shimosato Y; Ishihara K
    Cancer; 1982 Sep; 50(5):912-8. PubMed ID: 6807528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of malignant melanoma.
    Hirano T
    Acta Pathol Jpn; 1986 May; 36(5):733-43. PubMed ID: 3526811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of S-100 protein in melanocytic and neurogenic cutaneous tumors.
    Yambe H; Ishii Y; Tabuchi K; Isobe T; Kikuchi K
    Arch Dermatol Res; 1984; 276(3):160-4. PubMed ID: 6383227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of S-100 protein and neuron specific enolase (NSE) in melanocytes and the related tumors.
    Hachisuka H; Sakamoto F; Nomura H; Mori O; Sasai Y
    Acta Histochem; 1986; 80(2):215-23. PubMed ID: 3101377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study of melanocytic nevus and malignant melanoma with monoclonal antibodies against S-100 subunits.
    Cho KH; Hashimoto K; Taniguchi Y; Pietruk T; Zarbo RJ; An T
    Cancer; 1990 Aug; 66(4):765-71. PubMed ID: 2201426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Demonstration of S 100 protein in malignant melanoma of the skin. Pattern of distribution and significance for determination of tumor thickness].
    Flügge G; Rassner G
    Hautarzt; 1989 May; 40(5):290-5. PubMed ID: 2661501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of S-100 protein as an aid to the identification of melanocytic tumors.
    Cochran AJ; Wen DR; Herschman HR; Gaynor RB
    Int J Cancer; 1982 Sep; 30(3):295-7. PubMed ID: 6752046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100 protein: a marker for human malignant melanomas?
    Gaynor R; Herschman HR; Irie R; Jones P; Morton D; Cochran A
    Lancet; 1981 Apr; 1(8225):869-71. PubMed ID: 6112296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanoma.
    Abraha HD; Fuller LC; Du Vivier AW; Higgins EM; Sherwood RA
    Br J Dermatol; 1997 Sep; 137(3):381-5. PubMed ID: 9349333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excision of melanoma after initial biopsy. An immunohistochemical study.
    Penneys NS
    J Am Acad Dermatol; 1985 Dec; 13(6):995-8. PubMed ID: 4078107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogenous S-100B protein expression patterns in malignant melanoma and association with serum protein levels.
    Bánfalvi T; Udvarhelyi N; Orosz Z; Gergye M; Gilde K; Tímár J
    Oncology; 2003; 64(4):374-9. PubMed ID: 12759535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic malignant melanoma of the larynx.
    Pau H; De S; Spencer MG; Steele PR
    J Laryngol Otol; 2001 Nov; 115(11):925-7. PubMed ID: 11779314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary mucosal malignant melanoma: an immunohistochemical study of 12 cases with comparison to cutaneous and metastatic melanomas.
    Fitzgibbons PL; Chaurushiya PS; Nichols PW; Chandrasoma PT; Martin SE
    Hum Pathol; 1989 Mar; 20(3):269-72. PubMed ID: 2722176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved detection of aneuploidy in malignant melanoma using multiparameter flow cytometry for S100 protein and DNA content.
    Kamino H; Ratech H
    J Invest Dermatol; 1989 Sep; 93(3):392-6. PubMed ID: 2768839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microinvasive lentigo maligna melanoma.
    Penneys NS
    J Am Acad Dermatol; 1987 Oct; 17(4):675-80. PubMed ID: 3312317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-myc is not useful as prognostic immunohistochemical marker in cutaneous melanoma.
    Böni R; Bantschapp O; Müller B; Burg G
    Dermatology; 1998; 196(3):288-91. PubMed ID: 9621133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
    Zubovits J; Buzney E; Yu L; Duncan LM
    Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAS-positive loops and networks as a prognostic indicator in cutaneous malignant melanoma.
    Thies A; Mangold U; Moll I; Schumacher U
    J Pathol; 2001 Dec; 195(5):537-42. PubMed ID: 11745688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spindle cell tumours of the skin of debatable origin. An immunocytochemical study.
    Eusebi V; Ceccarelli C; Piscioli F; Cristofolini M; Azzopardi JG
    J Pathol; 1984 Nov; 144(3):189-99. PubMed ID: 6209370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.